Company Filing History:
Years Active: 1981-1983
Title: Akinobu Funatsu: Innovator in Immunoglobulin Production
Introduction
Akinobu Funatsu is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of immunology, particularly in the production of immunoglobulins. With a total of 2 patents to his name, his work focuses on enhancing the efficacy and safety of immunoglobulin-based therapies.
Latest Patents
One of Funatsu's latest patents is a method for the production of immunoglobulin having a high content of monomer. This innovative method involves fractionating immunoglobulin-containing materials in the presence of a water-soluble, basic nitrogen-containing organic compound. This approach effectively inhibits the by-production of undesirable aggregated molecules, resulting in immunoglobulin that is suitable for medical applications in immune prophylaxis and immunotherapy. The immunoglobulin produced through this method can be administered intravenously and has minimal side effects.
Another significant patent by Funatsu is the purification of a gammaglobulin derivative. This process involves treating S-sulfonated gammaglobulin with an ion exchanger in a buffer solution, allowing for the absorption and elution of single molecular S-sulfonated gammaglobulin. The outcome is a highly purified product with a high content of single molecules and low anticomplementary activity, making it suitable for industrial-scale applications.
Career Highlights
Akinobu Funatsu is associated with the Juridical Foundation the Chemo-sero-therapeutic Research Institute. His work at this institution has been pivotal in advancing research and development in immunological therapies.
Collaborations
Funatsu has collaborated with notable colleagues, including Komei Ohashi and Tetsuro Sato. Their combined expertise has contributed to the successful development of innovative immunological solutions.
Conclusion
Akinobu Funatsu's contributions to immunoglobulin production highlight his role as a key innovator in the field of immunology. His patents reflect a commitment to improving therapeutic options for patients, ensuring safer and more effective treatments.